The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Activated Prothrombin Complex Concentrate (aPCC) Market Research Report 2025
Synopsis
Activated Prothrombin Complex Concentrate (aPCC) is a blood coagulation factor complex commonly used to treat bleeding disorders, especially bleeding problems caused by coagulation factor deficiency. This complex contains a variety of coagulation factors, such as prothrombin, thrombin, fibrinogen, etc., which can help restore normal coagulation function by supplementing missing coagulation factors.
The global Activated Prothrombin Complex Concentrate (aPCC) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Activated Prothrombin Complex Concentrate (aPCC) include Takeda, Octapharma AG, CSL Behring GmbH and Grifols, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Activated Prothrombin Complex Concentrate (aPCC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activated Prothrombin Complex Concentrate (aPCC).
Report Scope
The Activated Prothrombin Complex Concentrate (aPCC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Activated Prothrombin Complex Concentrate (aPCC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Activated Prothrombin Complex Concentrate (aPCC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Octapharma AG
CSL Behring GmbH
Grifols
Segment by Type
3F Prothrombin Complex Concentrate
4F Prothrombin Complex Concentrate
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Activated Prothrombin Complex Concentrate (aPCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Activated Prothrombin Complex Concentrate (aPCC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Activated Prothrombin Complex Concentrate (aPCC) is a blood coagulation factor complex commonly used to treat bleeding disorders, especially bleeding problems caused by coagulation factor deficiency. This complex contains a variety of coagulation factors, such as prothrombin, thrombin, fibrinogen, etc., which can help restore normal coagulation function by supplementing missing coagulation factors.
The global Activated Prothrombin Complex Concentrate (aPCC) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Activated Prothrombin Complex Concentrate (aPCC) include Takeda, Octapharma AG, CSL Behring GmbH and Grifols, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Activated Prothrombin Complex Concentrate (aPCC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activated Prothrombin Complex Concentrate (aPCC).
Report Scope
The Activated Prothrombin Complex Concentrate (aPCC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Activated Prothrombin Complex Concentrate (aPCC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Activated Prothrombin Complex Concentrate (aPCC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Octapharma AG
CSL Behring GmbH
Grifols
Segment by Type
3F Prothrombin Complex Concentrate
4F Prothrombin Complex Concentrate
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Activated Prothrombin Complex Concentrate (aPCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Activated Prothrombin Complex Concentrate (aPCC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Activated Prothrombin Complex Concentrate (aPCC) Market Overview
1.1 Product Overview and Scope of Activated Prothrombin Complex Concentrate (aPCC)
1.2 Activated Prothrombin Complex Concentrate (aPCC) Segment by Type
1.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Market Value Comparison by Type (2024-2030)
1.2.2 3F Prothrombin Complex Concentrate
1.2.3 4F Prothrombin Complex Concentrate
1.3 Activated Prothrombin Complex Concentrate (aPCC) Segment by Application
1.3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Activated Prothrombin Complex Concentrate (aPCC) Market Size Estimates and Forecasts
1.4.1 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue 2019-2030
1.4.2 Global Activated Prothrombin Complex Concentrate (aPCC) Sales 2019-2030
1.4.3 Global Activated Prothrombin Complex Concentrate (aPCC) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Activated Prothrombin Complex Concentrate (aPCC) Market Competition by Manufacturers
2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Activated Prothrombin Complex Concentrate (aPCC) Average Price by Manufacturers (2019-2024)
2.4 Global Activated Prothrombin Complex Concentrate (aPCC) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Activated Prothrombin Complex Concentrate (aPCC), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Activated Prothrombin Complex Concentrate (aPCC), Product Type & Application
2.7 Activated Prothrombin Complex Concentrate (aPCC) Market Competitive Situation and Trends
2.7.1 Activated Prothrombin Complex Concentrate (aPCC) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Activated Prothrombin Complex Concentrate (aPCC) Players Market Share by Revenue
2.7.3 Global Activated Prothrombin Complex Concentrate (aPCC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Activated Prothrombin Complex Concentrate (aPCC) Retrospective Market Scenario by Region
3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Region: 2019-2030
3.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Region: 2019-2024
3.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Region: 2025-2030
3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region: 2019-2030
3.3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region: 2019-2024
3.3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region: 2025-2030
3.4 North America Activated Prothrombin Complex Concentrate (aPCC) Market Facts & Figures by Country
3.4.1 North America Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2030)
3.4.3 North America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Activated Prothrombin Complex Concentrate (aPCC) Market Facts & Figures by Country
3.5.1 Europe Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2030)
3.5.3 Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Market Facts & Figures by Country
3.6.1 Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2030)
3.6.3 Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Activated Prothrombin Complex Concentrate (aPCC) Market Facts & Figures by Country
3.7.1 Latin America Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2030)
3.7.3 Latin America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Activated Prothrombin Complex Concentrate (aPCC) Market Facts & Figures by Country
3.8.1 Middle East and Africa Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2019-2030)
4.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2019-2024)
4.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2025-2030)
4.1.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2019-2030)
4.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Type (2019-2030)
4.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Type (2019-2024)
4.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Type (2025-2030)
4.2.3 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2019-2030)
4.3 Global Activated Prothrombin Complex Concentrate (aPCC) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2019-2030)
5.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2019-2024)
5.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2025-2030)
5.1.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2019-2030)
5.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Application (2019-2030)
5.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Application (2019-2024)
5.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Application (2025-2030)
5.2.3 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application (2019-2030)
5.3 Global Activated Prothrombin Complex Concentrate (aPCC) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Activated Prothrombin Complex Concentrate (aPCC) Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Octapharma AG
6.2.1 Octapharma AG Corporation Information
6.2.2 Octapharma AG Description and Business Overview
6.2.3 Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Product Portfolio
6.2.5 Octapharma AG Recent Developments/Updates
6.3 CSL Behring GmbH
6.3.1 CSL Behring GmbH Corporation Information
6.3.2 CSL Behring GmbH Description and Business Overview
6.3.3 CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Product Portfolio
6.3.5 CSL Behring GmbH Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Corporation Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Activated Prothrombin Complex Concentrate (aPCC) Product Portfolio
6.4.5 Grifols Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Activated Prothrombin Complex Concentrate (aPCC) Industry Chain Analysis
7.2 Activated Prothrombin Complex Concentrate (aPCC) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Activated Prothrombin Complex Concentrate (aPCC) Production Mode & Process
7.4 Activated Prothrombin Complex Concentrate (aPCC) Sales and Marketing
7.4.1 Activated Prothrombin Complex Concentrate (aPCC) Sales Channels
7.4.2 Activated Prothrombin Complex Concentrate (aPCC) Distributors
7.5 Activated Prothrombin Complex Concentrate (aPCC) Customers
8 Activated Prothrombin Complex Concentrate (aPCC) Market Dynamics
8.1 Activated Prothrombin Complex Concentrate (aPCC) Industry Trends
8.2 Activated Prothrombin Complex Concentrate (aPCC) Market Drivers
8.3 Activated Prothrombin Complex Concentrate (aPCC) Market Challenges
8.4 Activated Prothrombin Complex Concentrate (aPCC) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Activated Prothrombin Complex Concentrate (aPCC) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Activated Prothrombin Complex Concentrate (aPCC) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Activated Prothrombin Complex Concentrate (aPCC) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Activated Prothrombin Complex Concentrate (aPCC) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Activated Prothrombin Complex Concentrate (aPCC), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Activated Prothrombin Complex Concentrate (aPCC), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Activated Prothrombin Complex Concentrate (aPCC), Product Type & Application
Table 12. Global Key Manufacturers of Activated Prothrombin Complex Concentrate (aPCC), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Activated Prothrombin Complex Concentrate (aPCC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activated Prothrombin Complex Concentrate (aPCC) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Activated Prothrombin Complex Concentrate (aPCC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2019-2024) & (K Units)
Table 18. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region (2019-2024)
Table 19. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2025-2030) & (K Units)
Table 20. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region (2025-2030)
Table 21. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Region (2019-2024)
Table 23. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Region (2025-2030)
Table 25. North America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2024) & (K Units)
Table 27. North America Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2025-2030) & (K Units)
Table 28. North America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units) by Type (2019-2024)
Table 51. Global Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units) by Type (2025-2030)
Table 52. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2019-2024)
Table 53. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2025-2030)
Table 54. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2019-2024)
Table 57. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2025-2030)
Table 58. Global Activated Prothrombin Complex Concentrate (aPCC) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Activated Prothrombin Complex Concentrate (aPCC) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units) by Application (2019-2024)
Table 61. Global Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units) by Application (2025-2030)
Table 62. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2019-2024)
Table 63. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2025-2030)
Table 64. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application (2019-2024)
Table 67. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application (2025-2030)
Table 68. Global Activated Prothrombin Complex Concentrate (aPCC) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Activated Prothrombin Complex Concentrate (aPCC) Price (US$/Unit) by Application (2025-2030)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Takeda Activated Prothrombin Complex Concentrate (aPCC) Product
Table 74. Takeda Recent Developments/Updates
Table 75. Octapharma AG Corporation Information
Table 76. Octapharma AG Description and Business Overview
Table 77. Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Product
Table 79. Octapharma AG Recent Developments/Updates
Table 80. CSL Behring GmbH Corporation Information
Table 81. CSL Behring GmbH Description and Business Overview
Table 82. CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Product
Table 84. CSL Behring GmbH Recent Developments/Updates
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Grifols Activated Prothrombin Complex Concentrate (aPCC) Product
Table 89. Grifols Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Activated Prothrombin Complex Concentrate (aPCC) Distributors List
Table 93. Activated Prothrombin Complex Concentrate (aPCC) Customers List
Table 94. Activated Prothrombin Complex Concentrate (aPCC) Market Trends
Table 95. Activated Prothrombin Complex Concentrate (aPCC) Market Drivers
Table 96. Activated Prothrombin Complex Concentrate (aPCC) Market Challenges
Table 97. Activated Prothrombin Complex Concentrate (aPCC) Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Activated Prothrombin Complex Concentrate (aPCC)
Figure 2. Global Activated Prothrombin Complex Concentrate (aPCC) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Activated Prothrombin Complex Concentrate (aPCC) Market Share by Type in 2023 & 2030
Figure 4. 3F Prothrombin Complex Concentrate Product Picture
Figure 5. 4F Prothrombin Complex Concentrate Product Picture
Figure 6. Global Activated Prothrombin Complex Concentrate (aPCC) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Activated Prothrombin Complex Concentrate (aPCC) Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Activated Prothrombin Complex Concentrate (aPCC) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Activated Prothrombin Complex Concentrate (aPCC) Sales (2019-2030) & (K Units)
Figure 13. Global Activated Prothrombin Complex Concentrate (aPCC) Average Price (US$/Unit) & (2019-2030)
Figure 14. Activated Prothrombin Complex Concentrate (aPCC) Report Years Considered
Figure 15. Activated Prothrombin Complex Concentrate (aPCC) Sales Share by Manufacturers in 2023
Figure 16. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Activated Prothrombin Complex Concentrate (aPCC) Players: Market Share by Revenue in 2023
Figure 18. Activated Prothrombin Complex Concentrate (aPCC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Activated Prothrombin Complex Concentrate (aPCC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2019-2030)
Figure 21. North America Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2019-2030)
Figure 22. United States Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2019-2030)
Figure 25. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Region (2019-2030)
Figure 33. China Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2019-2030)
Figure 41. Latin America Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2019-2030)
Figure 46. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Activated Prothrombin Complex Concentrate (aPCC) by Type (2019-2030)
Figure 51. Global Revenue Market Share of Activated Prothrombin Complex Concentrate (aPCC) by Type (2019-2030)
Figure 52. Global Activated Prothrombin Complex Concentrate (aPCC) Price (US$/Unit) by Type (2019-2030)
Figure 53. Global Sales Market Share of Activated Prothrombin Complex Concentrate (aPCC) by Application (2019-2030)
Figure 54. Global Revenue Market Share of Activated Prothrombin Complex Concentrate (aPCC) by Application (2019-2030)
Figure 55. Global Activated Prothrombin Complex Concentrate (aPCC) Price (US$/Unit) by Application (2019-2030)
Figure 56. Activated Prothrombin Complex Concentrate (aPCC) Value Chain
Figure 57. Activated Prothrombin Complex Concentrate (aPCC) Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
